AKT1 and type 2 diabetes mellitus: In the case of UCEC, insulin has been linked to tumor development through the PI3K/Akt and RAS/MAPK pathways,59 which further elaborates the potential anticancer effects of metformin, a common treatment for type 2 diabetes, through the RAS/MAPK pathway.36